What is the recommended regimen of ofloxacin 0.3% ear drops for acute otitis externa, and what alternative topical agents should be used if the tympanic membrane is perforated or the patient has a fluoroquinolone allergy?

Ofloxacin 0.3% Ear Drops for Acute Otitis Externa

For acute otitis externa with an intact tympanic membrane, use ofloxacin 0.3% ear drops: 5 drops once daily for 7 days in children 6 months to 13 years, or 10 drops once daily for 7 days in patients ≥13 years old. 1

Dosing Regimen

The FDA-approved dosing for otitis externa is straightforward 1:

• Pediatric patients (6 months to 13 years): 5 drops (0.25 mL) into affected ear once daily × 7 days
• Patients ≥13 years: 10 drops (0.5 mL) into affected ear once daily × 7 days

This once-daily, 7-day regimen achieves a 91% clinical cure rate (95% in children, 88% in adolescents/adults), with 68% of patients cured within 7 days 2. The simplified dosing improves adherence (98% compliance) compared to traditional four-times-daily regimens 2.

Proper Administration Technique

Critical steps for effective drug delivery 3, 1:

• Warm the bottle in hand for 1-2 minutes before instillation (prevents dizziness from cold solution)
• Patient lies with affected ear upward
• Instill drops to fill the ear canal
• Maintain position for 3-5 minutes (use a timer)
• Perform gentle to-and-fro movement of pinna OR tragal pumping to eliminate trapped air
• Wipe excess; leave canal open (do not plug)

When to Use a Wick

Place a compressed cellulose wick if 3:

• Severe canal edema prevents drop penetration
• Most of the tympanic membrane cannot be visualized
• Drops cannot adequately enter the canal

The wick expands with moisture, facilitating drug delivery and reducing edema. It typically falls out spontaneously within 24 hours to a few days as inflammation resolves. If wick placement is impossible due to severe edema, consider adding systemic antibiotics 3.

Aural Toilet

Perform aural toilet before initiating drops 3:

• Remove inflammatory debris, obstructing cerumen, or foreign objects
• Methods: gentle body-temperature water/saline lavage, suction under visualization, or dry mopping with cotton-tipped applicator
• Caution: In diabetic or immunocompromised patients, avoid irrigation with tap water (risk of malignant otitis externa); use atraumatic suctioning under microscopic guidance instead 3

Perforated Tympanic Membrane or Tympanostomy Tubes

If the tympanic membrane is perforated or status is unknown, ofloxacin remains the preferred choice because it is non-ototoxic 3, 1, 4. This is a critical advantage over aminoglycoside-containing drops (neomycin/polymyxin B), which carry ototoxicity risk with prolonged or repetitive use in non-intact membranes 3.

For perforated membranes, the dosing changes 1:

• Chronic suppurative otitis media (≥12 years): 10 drops twice daily × 14 days
• Acute otitis media with tympanostomy tubes (1-12 years): 5 drops twice daily × 10 days

The guideline explicitly recommends non-ototoxic topical preparations when perforation is known or suspected 3. Ofloxacin is the only ototopical fluoroquinolone approved for use with non-intact tympanic membranes, showing no ototoxicity in animal or human studies 5.

Fluoroquinolone Allergy

If the patient has a documented fluoroquinolone allergy, alternative options include:

• Acidifying drops with corticosteroids: Acetic acid 2% with hydrocortisone 1% (3 drops three times daily) 6
• Aluminum acetate (Burow's solution) with corticosteroid: For perforated membranes specifically 6
• Avoid: Neomycin-containing preparations if perforation suspected (ototoxicity risk) and if patient has neomycin allergy (common contact sensitizer) 3

Key Pitfalls to Avoid

1. Do NOT prescribe oral antibiotics for uncomplicated acute otitis externa 3. They are inactive against Pseudomonas aeruginosa and Staphylococcus aureus (the primary pathogens), have systemic side effects, and promote resistance. Topical therapy alone is first-line treatment 4.

2. Do NOT use aminoglycoside-containing drops (neomycin/polymyxin B) if tympanic membrane status is uncertain or perforation exists—risk of permanent hearing loss with prolonged use 3, 4.

3. Ensure adequate contact time: Patients must maintain the ear-up position for the full 3-5 minutes. Inadequate dwell time is a common cause of treatment failure 3.

4. Continue drops for full 7 days even if symptoms improve earlier, to prevent relapse 3.

5. Keep ear dry during treatment: Cover ear canal with petroleum jelly-coated cotton or earplug when showering 3.

Microbiologic Coverage

Ofloxacin achieves extremely high local concentrations (389-2850 mcg/g in otorrhea) 1, providing excellent coverage against the primary otitis externa pathogens 1, 2:

• Pseudomonas aeruginosa (96% eradication rate)
• Staphylococcus aureus (96% eradication rate)
• Escherichia coli
• Also covers Proteus mirabilis, Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae

The high local concentrations overcome typical fluoroquinolone resistance patterns seen with systemic therapy 3.

Pain Management

Address pain aggressively 3. Ofloxacin reduces median time to pain cessation, but additional analgesia is often needed initially. The guideline emphasizes adequate pain relief as a primary treatment goal alongside antimicrobial therapy.